Compile Data Set for Download or QSAR
Report error Found 43 Enz. Inhib. hit(s) with all data for entry = 50011952
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM14680(2-formylphenyl dihydrogen phosphate | Fragment 10 ...)
Affinity DataIC50: 2.00E+5nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112464(Phosphoric acid mono-(8-hydroxy-3,4-dihydro-2H-qui...)
Affinity DataIC50: 3.00E+5nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112470(Phosphoric acid mono-(2,6-diformyl-phenyl) ester |...)
Affinity DataIC50: 5.00E+5nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112456(Phosphoric acid mono-(4-amino-phenyl) ester | CHEM...)
Affinity DataIC50: 6.00E+5nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112450({[4-(benzyloxy)phenyl]amino}carbonylphosphonic aci...)
Affinity DataIC50: 8.00E+5nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM14679(Fragment 9 | CHEMBL25186 | 2-formyl-6-methoxypheny...)
Affinity DataIC50: 9.00E+5nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM24514(CHEMBL24231 | 4-nitrophenoxyphosphonic acid | 4-ni...)
Affinity DataIC50: 1.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112452(Phosphoric acid mono-naphthalen-2-yl ester | CHEMB...)
Affinity DataIC50: 1.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50080266(Phosphoric acid mono-naphthalen-1-yl ester | CHEMB...)
Affinity DataIC50: 1.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112460(Phosphoric acid mono-(4-trifluoromethylsulfanyl-ph...)
Affinity DataIC50: 1.20E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112467(Phosphoric acid mono-p-tolyl ester | CHEMBL24164)
Affinity DataIC50: 2.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112448(Fosfosal | 2-Phosphonooxy-benzoic acid | CHEMBL287...)
Affinity DataIC50: 2.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112458(Phosphoric acid 2-formyl-phenyl ester isopropyl es...)
Affinity DataIC50: 2.10E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112442([(3,4,5-trimethoxyphenyl)amino]carbonylphosphonic ...)
Affinity DataIC50: 2.10E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM14685(cyclohexylmethyl 2-formylphenyl hydrogen phosphate...)
Affinity DataIC50: 2.30E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112457(Phosphoric acid mono-(3-formyl-phenyl) ester | CHE...)
Affinity DataIC50: 2.40E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112445([Hydroxy-(4-propoxy-phenyl)-methyl]-phosphonic aci...)
Affinity DataIC50: 2.40E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM14675(CHEMBL26128 | phenoxyphosphonic acid | Fragment 5 ...)
Affinity DataIC50: 2.50E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112454(3-Phosphonooxy-naphthalene-2-carboxylic acid methy...)
Affinity DataIC50: 3.20E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112453(Phosphoric acid 2-formyl-phenyl ester methyl ester...)
Affinity DataIC50: 3.30E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112469(Phosphoric acid mono-(2-acetyl-naphthalen-1-yl) es...)
Affinity DataIC50: 3.50E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112472(Phosphoric acid mono-(2-chloro-phenyl) ester | CHE...)
Affinity DataIC50: 3.50E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112461({[4-(ethoxycarbonyl)phenyl]amino}carbonylphosphoni...)
Affinity DataIC50: 3.60E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112462([(4-butoxyphenyl)amino]carbonylphosphonic acid | C...)
Affinity DataIC50: 3.90E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112468(4-Phosphonooxy-benzoic acid methyl ester | CHEMBL2...)
Affinity DataIC50: 4.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112443(Phosphoric acid mono-(4-tert-butyl-phenyl) ester |...)
Affinity DataIC50: 4.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112440({[2-(trifluoromethoxy)phenyl]amino}carbonylphospho...)
Affinity DataIC50: 4.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112466(Phosphoric acid mono-(4-methoxy-phenyl) ester | CH...)
Affinity DataIC50: 4.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112449(3-Phosphonooxy-benzoic acid methyl ester | CHEMBL2...)
Affinity DataIC50: 4.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112447(Phosphoric acid mono-m-tolyl ester | CHEMBL287555)
Affinity DataIC50: 4.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112441((benzylamino)carbonylphosphonic acid | CHEMBL28727...)
Affinity DataIC50: 4.40E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM14687([(4-ETHYLPHENYL)AMINO]CARBONYLPHOSPHONIC ACID | CH...)
Affinity DataIC50: 4.40E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50011995(CHEMBL26001 | hydroxy(naphthalen-2-yl)methylphosph...)
Affinity DataIC50: 4.40E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM14683([hydroxy(naphthalen-1-yl)methyl]phosphonic acid | ...)
Affinity DataIC50: 5.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112446([(2-phenylethyl)amino]carbonylphosphonic acid | CH...)
Affinity DataIC50: 5.00E+6nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112444([Hydroxy-(4-isopropyl-phenyl)-methyl]-phosphonic a...)
Affinity DataIC50: 1.00E+7nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112455(Alpha Hydroxy benzylphosphonate | (Hydroxy-phenyl-...)
Affinity DataIC50: 1.00E+7nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112439((Cyclohexyl-hydroxy-methyl)-phosphonic acid | CHEM...)
Affinity DataIC50: 1.00E+7nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112465([Hydroxy-(2-methoxy-phenyl)-methyl]-phosphonic aci...)
Affinity DataIC50: 1.00E+7nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112451(Phosphoric acid mono-(2,6-dimethyl-phenyl) ester |...)
Affinity DataIC50: 1.00E+7nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112463((Biphenyl-4-yl-hydroxy-methyl)-phosphonic acid | C...)
Affinity DataIC50: 1.00E+7nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112459(Phosphoric acid mono-(2-cyano-8-hydroxy-8aH-quinol...)
Affinity DataIC50: 1.00E+7nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Aventis Pharma

Curated by ChEMBL
LigandPNGBDBM50112471(Phosphoric acid mono-(8-hydroxy-8aH-quinolin-1-yl)...)
Affinity DataIC50: 1.00E+7nMAssay Description:The compound was evaluated for its binding affinity towards phosphotyrosine binding pocket of Src protein tyrosine kinase SH2 domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed